Sapna Ravi Kudchadkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sapna Ravi Kudchadkar has a total of 431 co-authors. Here are the top co-authors by number of shared publications:
- Donald H. Shaffner
Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University School of Medicine, 1800 Orleans Street, Bloomberg Children's Center, Suite 6302, Baltimore, MD 21287, United States
5 shared publications Dale M. Needham
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
4 shared publicationsEwa Kulikowicz
Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University School of Medicine, 1800 Orleans Street, Bloomberg Children's Center Suite 6302, Baltimore, MD 21287 United States
4 shared publicationsJustin T. Hamrick
Department of Anesthesiology, Rady Children's Hospital, 3020 Children's Way, San Diego, CA 92123 United States
4 shared publicationsMyron Yaster
Departments of Anesthesiology & Critical Care Medicine, Pediatrics, and Neurosurgery, Johns Hopkins University School of Medicine, Charlotte R. Bloomberg Children's Center, Baltimore, MD
4 shared publications- Niranjan Kissoon
University of British Columbia, Vancouver, Canada
4 shared publications
Latest Publications
- 11 September 2026
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 27 (11) , 1465-1476
Trust, Advocacy, Inequity, and Information: A Qualitative Study of PICU Communication Experiences Among Low-Income Families in the United States
OBJECTIVES: Communication challenges and barriers are common during PICU stays, but prior studies have rarely focused on historically marginalized groups such as families with low socioeconomic status and families of color. We aimed to characterize these experiences. DESIGN: Semi-structured interviews were conducted from October 2023 to April 2025. Interviews were audio-recorded, transcribed verbatim, analyzed, and coded using a constant comparative method. SETTING: A PICU at a tertiary-care academic center in the United States. Participants: Seventeen families, including 13 mothers, 7 fathers, and 2 grandparents of children with income-based Medicaid insurance admitted to the PICU for at least 5 days. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Thirteen of 22 interviewees were Black, African American, or Multiracial, 7 were White, and 2 did not indicate race. Major themes included 1) healthcare team behaviors that build or lose family trust; 2) importance of parental advocacy and valuing parent perspective; 3) intersection of race and healthcare experience; and 4) diverse preferences for obtaining information. Families’ trust in their healthcare team was influenced by both medical and socioemotional behaviors. Parents desired recognition as experts in their child and trusted the team more when their perspective was included. For some families, experiences with discrimination impacted their trust levels and care experiences. Finally, families obtained information from PICU structures such as rounds but also sought a variety of other sources. CONCLUSIONS: This interview study characterized PICU communication experiences among low-income families with diverse representation. Our findings identified how communication behaviors can build and erode family trust in the healthcare team. We also elicited preferences for obtaining information, which could inform interventions to improve information sharing. Future research on how to develop and assess interventions that improve family trust and satisfaction in inpatient care is needed.
- 11 September 2026
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 27 (11) , 1465-1476
Trust, Advocacy, Inequity, and Information: A Qualitative Study of PICU Communication Experiences Among Low-Income Families in the United States
OBJECTIVES: Communication challenges and barriers are common during PICU stays, but prior studies have rarely focused on historically marginalized groups such as families with low socioeconomic status and families of color. We aimed to characterize these experiences. DESIGN: Semi-structured interviews were conducted from October 2023 to April 2025. Interviews were audio-recorded, transcribed verbatim, analyzed, and coded using a constant comparative method. SETTING: A PICU at a tertiary-care academic center in the United States. Participants: Seventeen families, including 13 mothers, 7 fathers, and 2 grandparents of children with income-based Medicaid insurance admitted to the PICU for at least 5 days. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Thirteen of 22 interviewees were Black, African American, or Multiracial, 7 were White, and 2 did not indicate race. Major themes included 1) healthcare team behaviors that build or lose family trust; 2) importance of parental advocacy and valuing parent perspective; 3) intersection of race and healthcare experience; and 4) diverse preferences for obtaining information. Families’ trust in their healthcare team was influenced by both medical and socioemotional behaviors. Parents desired recognition as experts in their child and trusted the team more when their perspective was included. For some families, experiences with discrimination impacted their trust levels and care experiences. Finally, families obtained information from PICU structures such as rounds but also sought a variety of other sources. CONCLUSIONS: This interview study characterized PICU communication experiences among low-income families with diverse representation. Our findings identified how communication behaviors can build and erode family trust in the healthcare team. We also elicited preferences for obtaining information, which could inform interventions to improve information sharing. Future research on how to develop and assess interventions that improve family trust and satisfaction in inpatient care is needed.
- Open Access
- 6 August 2026
- Published by Wiley in Pediatric Anesthesia
- Vol. 36 (11) , 1361-1374
Effects of Esketamine on Emergence Delirium in Children Undergoing Sevoflurane Anesthesia: A Systematic Review, Meta‐Analysis, and Trial Sequential Analysis
Background: Emergence delirium is a frequent and distressing postoperative complication in children, particularly following sevoflurane‐based anesthesia. Despite its clinical importance, the optimal preventive strategy remains under investigation. This study aims to systematically evaluate the efficacy and safety of esketamine in preventing emergence delirium in pediatric patients undergoing sevoflurane‐based general anesthesia. Methods: We systematically searched seven databases and registries through 27 March 2026. Randomized controlled trials that compared esketamine with placebo in children undergoing surgical procedures were included. The primary outcome was the incidence of emergence delirium. Secondary outcomes were postoperative pain scores, extubation time, post‐anesthesia care unit stay, and postoperative nausea and vomiting. Data were synthesized using random‐effects models, with risk ratios for dichotomous outcomes and mean differences or standardized mean differences for continuous outcomes. Meta‐regression and trial sequential analysis were performed. The risk of bias was assessed using the revised Cochrane risk‐of‐bias tool for randomized trials, and the certainty of the evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation approach. Results: Eight randomized controlled trials involving 916 patients were included. Esketamine significantly reduced the incidence of emergence delirium versus placebo (risk ratio = 0.35; 95% confidence interval: 0.26–0.48; p < 0.0001). No significant differences were observed between dosing regimens, surgical types, routes of administration, or timing of administration. Pain scores were significantly lower with esketamine (standardized mean difference = −0.58; 95% confidence interval: −0.79 to −0.37; p < 0.0001). Extubation time was modestly prolonged (mean difference = 1.72 min; 95% confidence interval: 0.20–3.24; p = 0.0267). Meta‐regression revealed a statistically significant association between emergence delirium risk ratios and anesthesia duration (β = 0.98, p = 0.042), with no other significant associations observed for the other covariates. Post‐anesthesia care unit stay showed no statistically significant difference, while postoperative nausea and vomiting was significantly reduced with esketamine (risk ratio = 0.69; 95% confidence interval: 0.49–0.97; p = 0.0304). No study was at high‐risk of bias; four studies raised some concerns. Certainty of evidence was moderate, except for extubation time, which was low. Conclusions: Esketamine demonstrates promising efficacy for preventing emergence delirium and improving postoperative pain in children. Prospero: CRD420251230407.
- 6 August 2026
- Published by Wiley in Pediatric Anesthesia
- Vol. 36 (11) , 1361-1374
Open AccessEffects of Esketamine on Emergence Delirium in Children Undergoing Sevoflurane Anesthesia: A Systematic Review, Meta‐Analysis, and Trial Sequential Analysis
Background: Emergence delirium is a frequent and distressing postoperative complication in children, particularly following sevoflurane‐based anesthesia. Despite its clinical importance, the optimal preventive strategy remains under investigation. This study aims to systematically evaluate the efficacy and safety of esketamine in preventing emergence delirium in pediatric patients undergoing sevoflurane‐based general anesthesia. Methods: We systematically searched seven databases and registries through 27 March 2026. Randomized controlled trials that compared esketamine with placebo in children undergoing surgical procedures were included. The primary outcome was the incidence of emergence delirium. Secondary outcomes were postoperative pain scores, extubation time, post‐anesthesia care unit stay, and postoperative nausea and vomiting. Data were synthesized using random‐effects models, with risk ratios for dichotomous outcomes and mean differences or standardized mean differences for continuous outcomes. Meta‐regression and trial sequential analysis were performed. The risk of bias was assessed using the revised Cochrane risk‐of‐bias tool for randomized trials, and the certainty of the evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation approach. Results: Eight randomized controlled trials involving 916 patients were included. Esketamine significantly reduced the incidence of emergence delirium versus placebo (risk ratio = 0.35; 95% confidence interval: 0.26–0.48; p < 0.0001). No significant differences were observed between dosing regimens, surgical types, routes of administration, or timing of administration. Pain scores were significantly lower with esketamine (standardized mean difference = −0.58; 95% confidence interval: −0.79 to −0.37; p < 0.0001). Extubation time was modestly prolonged (mean difference = 1.72 min; 95% confidence interval: 0.20–3.24; p = 0.0267). Meta‐regression revealed a statistically significant association between emergence delirium risk ratios and anesthesia duration (β = 0.98, p = 0.042), with no other significant associations observed for the other covariates. Post‐anesthesia care unit stay showed no statistically significant difference, while postoperative nausea and vomiting was significantly reduced with esketamine (risk ratio = 0.69; 95% confidence interval: 0.49–0.97; p = 0.0304). No study was at high‐risk of bias; four studies raised some concerns. Certainty of evidence was moderate, except for extubation time, which was low. Conclusions: Esketamine demonstrates promising efficacy for preventing emergence delirium and improving postoperative pain in children. Prospero: CRD420251230407.
- 23 June 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
Live Interactive Music Therapy Across the Perioperative Continuum: A Scoping Review
Music therapy is a nonpharmacologic, patient-centered intervention increasingly used in perioperative settings to improve the surgical experience for patients and their families. Despite growing evidence, music therapy’s integration into anesthesia care remains variable, highlighting a need to synthesize the current landscape of music therapy in this clinical context. This scoping review aimed to map the primary characteristics and impacts of live interactive music therapy delivered by a certified music therapist across the perioperative continuum and identify gaps in the literature to guide future research and practice in perioperative settings. Following PRISMA-ScR guidance, database searches were conducted October 2024 to June 2025 using key medical subject headings (MeSH) terms. Inclusion criteria specified (1) live or recorded music therapy delivered by a certified music therapist and (2) intervention timing within 24 hours pre- to 72 hours post-operation. The initial search yielded 2095 articles. After abstract screening, 1049 remained and underwent full-text review. 25 articles met criteria and were included in data extraction. The 25 articles included 1821 patients aged 9-months- to 94-years-old across diverse surgical specialties. Music therapy was delivered preoperatively (n = 17), intraoperatively (n = 8), and postoperatively (n = 15), with inclusion of flexible and protocolized approaches. Pediatric music therapy was more frequently delivered preoperatively, emphasizing play-based, active engagement. Adult music therapy was more evenly distributed across perioperative timepoints, emphasizing introspective, emotion-focused approaches. Selected outcome measures reflected these differences, with pediatric effects captured through behavioral observation (e.g, modified-Yale Perioperative Anxiety Scale [m-YPAS]), whereas adult outcomes relied more heavily on self-reporting (eg, visual analog scale [VAS]). Postoperatively, pediatric and adult music therapy approaches were more aligned across age groups given both used relaxation-based approaches. Perioperative music therapy is a feasible, low-risk adjunct that may complement existing pharmacologic strategies to support anxiety, mood, and pain with minimal interruption to patient care for teams with access to this resource. Limitations including small sample sizes, expectancy effects, inconsistent music therapy intervention reporting, and lack of therapist-contact controls prompt cautious interpretation. Future research should explore intraoperative delivery logistics, dose–response relationships, integration of multimodal outcomes, and anesthesia team perspectives to guide practical integration of music therapy into the anesthesia armamentarium.
- 23 June 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
Live Interactive Music Therapy Across the Perioperative Continuum: A Scoping Review
Music therapy is a nonpharmacologic, patient-centered intervention increasingly used in perioperative settings to improve the surgical experience for patients and their families. Despite growing evidence, music therapy’s integration into anesthesia care remains variable, highlighting a need to synthesize the current landscape of music therapy in this clinical context. This scoping review aimed to map the primary characteristics and impacts of live interactive music therapy delivered by a certified music therapist across the perioperative continuum and identify gaps in the literature to guide future research and practice in perioperative settings. Following PRISMA-ScR guidance, database searches were conducted October 2024 to June 2025 using key medical subject headings (MeSH) terms. Inclusion criteria specified (1) live or recorded music therapy delivered by a certified music therapist and (2) intervention timing within 24 hours pre- to 72 hours post-operation. The initial search yielded 2095 articles. After abstract screening, 1049 remained and underwent full-text review. 25 articles met criteria and were included in data extraction. The 25 articles included 1821 patients aged 9-months- to 94-years-old across diverse surgical specialties. Music therapy was delivered preoperatively (n = 17), intraoperatively (n = 8), and postoperatively (n = 15), with inclusion of flexible and protocolized approaches. Pediatric music therapy was more frequently delivered preoperatively, emphasizing play-based, active engagement. Adult music therapy was more evenly distributed across perioperative timepoints, emphasizing introspective, emotion-focused approaches. Selected outcome measures reflected these differences, with pediatric effects captured through behavioral observation (e.g, modified-Yale Perioperative Anxiety Scale [m-YPAS]), whereas adult outcomes relied more heavily on self-reporting (eg, visual analog scale [VAS]). Postoperatively, pediatric and adult music therapy approaches were more aligned across age groups given both used relaxation-based approaches. Perioperative music therapy is a feasible, low-risk adjunct that may complement existing pharmacologic strategies to support anxiety, mood, and pain with minimal interruption to patient care for teams with access to this resource. Limitations including small sample sizes, expectancy effects, inconsistent music therapy intervention reporting, and lack of therapist-contact controls prompt cautious interpretation. Future research should explore intraoperative delivery logistics, dose–response relationships, integration of multimodal outcomes, and anesthesia team perspectives to guide practical integration of music therapy into the anesthesia armamentarium.
- Open Access
- 31 March 2026
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 8 (4) , e1389
Is There Any Dose of Benzodiazepines Safe for Delirium in the PICU? A Secondary Analysis of the PICU Up! Pilot Trial Dataset
IMPORTANCE: A better understanding of the relationship between sedative dose and PICU delirium is crucial for delirium prevention. OBJECTIVES: To identify risk factors for delirium in critically ill children and characterize the dose-response relationship between benzodiazepine administration and next-day delirium in the PICU. DESIGN, SETTING, AND PARTICIPANTS: A secondary analysis of 10,644 patient-days from prospectively collected data, including sedative and analgesic use and delirium screening from the multicenter, randomized PICU Up! pilot trial, including seven PICUs and 1,006 patients. MAIN OUTCOMES AND MEASURES: Delirium odds were evaluated using a multivariable logistic regression model adjusted for known delirium risk factors. RESULTS: Benzodiazepines, opioids, and dexmedetomidine were commonly used in the PICU. A higher previous-day benzodiazepine dose was associated with increased odds of delirium on a given day with an adjusted odds ratio (aOR) of 1.12 per midazolam milligram equivalent per kilogram (95% CI, 1.02–1.25; p = 0.020). The most pronounced increase in delirium risk occurred at the lowest doses, between 0 and 0.01 mg/kg ( p = 0.010), with risk continuing to rise at higher doses. Previous-day opioid dose was not associated with changes in the odds of delirium (aOR, 1.00; 95% CI, 1.00–1.00; p = 0.892). Any previous-day dexmedetomidine administration was associated with increased odds of next-day delirium (aOR, 1.26; 95% CI, 1.04–1.52; p = 0.019). Additionally, same-day physical restraint use was associated with increased odds of delirium (aOR, 1.72; 95% CI, 1.27–2.31; p < 0.001). CONCLUSIONS AND RELEVANCE: No safe benzodiazepine threshold was identified in critically ill children, with delirium risk increased even at minimal doses. The greatest increase in odds occurred at the lowest doses. Hence, regardless of dose, benzodiazepine use should be minimized or eliminated whenever possible. Physical restraints and dexmedetomidine use were also associated with increased risk of delirium; thus, a tailored approach for each patient with an emphasis on judicious use is critical.
- 31 March 2026
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 8 (4) , e1389
Open AccessIs There Any Dose of Benzodiazepines Safe for Delirium in the PICU? A Secondary Analysis of the PICU Up! Pilot Trial Dataset
IMPORTANCE: A better understanding of the relationship between sedative dose and PICU delirium is crucial for delirium prevention. OBJECTIVES: To identify risk factors for delirium in critically ill children and characterize the dose-response relationship between benzodiazepine administration and next-day delirium in the PICU. DESIGN, SETTING, AND PARTICIPANTS: A secondary analysis of 10,644 patient-days from prospectively collected data, including sedative and analgesic use and delirium screening from the multicenter, randomized PICU Up! pilot trial, including seven PICUs and 1,006 patients. MAIN OUTCOMES AND MEASURES: Delirium odds were evaluated using a multivariable logistic regression model adjusted for known delirium risk factors. RESULTS: Benzodiazepines, opioids, and dexmedetomidine were commonly used in the PICU. A higher previous-day benzodiazepine dose was associated with increased odds of delirium on a given day with an adjusted odds ratio (aOR) of 1.12 per midazolam milligram equivalent per kilogram (95% CI, 1.02–1.25; p = 0.020). The most pronounced increase in delirium risk occurred at the lowest doses, between 0 and 0.01 mg/kg ( p = 0.010), with risk continuing to rise at higher doses. Previous-day opioid dose was not associated with changes in the odds of delirium (aOR, 1.00; 95% CI, 1.00–1.00; p = 0.892). Any previous-day dexmedetomidine administration was associated with increased odds of next-day delirium (aOR, 1.26; 95% CI, 1.04–1.52; p = 0.019). Additionally, same-day physical restraint use was associated with increased odds of delirium (aOR, 1.72; 95% CI, 1.27–2.31; p < 0.001). CONCLUSIONS AND RELEVANCE: No safe benzodiazepine threshold was identified in critically ill children, with delirium risk increased even at minimal doses. The greatest increase in odds occurred at the lowest doses. Hence, regardless of dose, benzodiazepine use should be minimized or eliminated whenever possible. Physical restraints and dexmedetomidine use were also associated with increased risk of delirium; thus, a tailored approach for each patient with an emphasis on judicious use is critical.
- 11 November 2025
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 14 (1) , e2
Rethinking isoflurane for paediatric ICU sedation
- 11 November 2025
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 14 (1) , e2
Rethinking isoflurane for paediatric ICU sedation
- Open Access
- 12 August 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e948715
N-Acetylcysteine and Hemodialysis in Severe Acetaminophen Toxicity in a 15-Year-Old Adolescent: A Case Report
BACKGROUND Acetaminophen toxicity is a leading cause of liver injury in adolescents and is usually treated with N-acetylcysteine (NAC). Rarely, adjunctive therapies, including hemodialysis (HD) and fomepizole, are required. This report describes the case of a 15-year-old male adolescent who required 2 hemodialysis sessions greater than 24 hours apart after a massive, intentional ingestion of acetaminophen. CASE REPORT A 15-year-old male patient presented to care after a single, intentional ingestion of approximately 195 g of extended-release acetaminophen. He was started on NAC therapy, and due to concern for early mitochondrial failure, he underwent intermittent HD, with reduction of his acetaminophen level. However, over 24 hours later, his transaminases increased and liver synthetic function declined, and he underwent HD a second time. There was no evidence of bezoar formation on computed tomography (CT) scan, suggesting that ongoing absorption was due to the extended-release formulation consumed. After his second HD session, his laboratory values normalized and he was medically cleared for transfer to psychiatry. CONCLUSIONS The need for a second HD session in acetaminophen toxicity >24 hours after an initial successful HD session is unprecedented. Given an increasing market of extended-release products and the potential for co-ingestions with medications that slow gastrointestinal motility, HD may be more frequently employed going forward, potentially multiple times. While central lines should be removed promptly when no longer needed, we advise caution in removing dialysis catheters within 24 hours of initial HD in these patients, given the need to repeat HD in this case.
- 12 August 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e948715
Open AccessN-Acetylcysteine and Hemodialysis in Severe Acetaminophen Toxicity in a 15-Year-Old Adolescent: A Case Report
BACKGROUND Acetaminophen toxicity is a leading cause of liver injury in adolescents and is usually treated with N-acetylcysteine (NAC). Rarely, adjunctive therapies, including hemodialysis (HD) and fomepizole, are required. This report describes the case of a 15-year-old male adolescent who required 2 hemodialysis sessions greater than 24 hours apart after a massive, intentional ingestion of acetaminophen. CASE REPORT A 15-year-old male patient presented to care after a single, intentional ingestion of approximately 195 g of extended-release acetaminophen. He was started on NAC therapy, and due to concern for early mitochondrial failure, he underwent intermittent HD, with reduction of his acetaminophen level. However, over 24 hours later, his transaminases increased and liver synthetic function declined, and he underwent HD a second time. There was no evidence of bezoar formation on computed tomography (CT) scan, suggesting that ongoing absorption was due to the extended-release formulation consumed. After his second HD session, his laboratory values normalized and he was medically cleared for transfer to psychiatry. CONCLUSIONS The need for a second HD session in acetaminophen toxicity >24 hours after an initial successful HD session is unprecedented. Given an increasing market of extended-release products and the potential for co-ingestions with medications that slow gastrointestinal motility, HD may be more frequently employed going forward, potentially multiple times. While central lines should be removed promptly when no longer needed, we advise caution in removing dialysis catheters within 24 hours of initial HD in these patients, given the need to repeat HD in this case.
- 3 October 2024
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 25 (10) , 963-965
Women in Pediatric Critical Care Medicine: Translating the Truth in the Trend*
- 3 October 2024
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 25 (10) , 963-965
Women in Pediatric Critical Care Medicine: Translating the Truth in the Trend*
- Open Access
- 19 September 2024
- Published by Elsevier in Australian Critical Care
- Vol. 38 (2) , 101113
Practices of assessment of pain, sedation, iatrogenic withdrawal syndrome, and delirium in European paediatric intensive care units: A secondary analysis of the European Prevalence of Acute Rehab for Kids in the paediatric intensive care unit study
- 19 September 2024
- Published by Elsevier in Australian Critical Care
- Vol. 38 (2) , 101113
Open AccessPractices of assessment of pain, sedation, iatrogenic withdrawal syndrome, and delirium in European paediatric intensive care units: A secondary analysis of the European Prevalence of Acute Rehab for Kids in the paediatric intensive care unit study
- 5 September 2024
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 25 (9) , 863-866
Decision Regret and Satisfaction: Moving Toward Improved Communication and Shared Decision-Making in PICUs*
- 5 September 2024
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 25 (9) , 863-866
Decision Regret and Satisfaction: Moving Toward Improved Communication and Shared Decision-Making in PICUs*
- 4 June 2024
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 25 (10) , 880-888
Delirium Screening in Critically Ill Children: Secondary Analysis of the Multicenter PICU Up! Pilot Trial Dataset, 2019–2020*
OBJECTIVES: To determine the patient-level factors associated with performing daily delirium screening in PICUs with established delirium screening practices. DESIGN: A secondary analysis of 2019–2020 prospective data from the baseline phase of the PICU Up! pilot stepped-wedge multicenter trial (NCT03860168). SETTING: Six PICUs in the United States. PATIENTS: One thousand sixty-four patients who were admitted to a PICU for 3 or more days. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of 1064 patients, 74% (95% CI, 71–76%) underwent delirium screening at least once during their PICU stay. On 57% of the 8965 eligible patient days, screening was conducted. The overall prevalence of delirium was 46% across all screened days, and 64% of screened patients experienced delirium at some point during their PICU stay. Factors associated with greater adjusted odds ratio (aOR) of increased daily delirium screening included PICU stay longer than 15 days compared with 1–3 days (aOR 3.36 [95% CI, 2.62–4.30]), invasive mechanical ventilation as opposed to room air (aOR 1.67 [95% CI, 1.32–2.12]), dexmedetomidine infusions (aOR 1.23 [95% CI, 1.04–1.44]) and propofol infusions (aOR 1.55 [95% CI, 1.08–2.23]). Conversely, decreased aOR of daily delirium screening was associated with female gender (aOR 0.78 [95% CI, 0.63–0.96]), and the administration of continuous infusions of opioids (aOR 0.75 [95% CI, 0.63–0.90]) or ketamine (aOR 0.48 [95% CI, 0.29–0.79]). Neither patient age, the presence of family or physical restraints, or benzodiazepine infusions were associated with daily delirium screening rates. CONCLUSIONS: In the 2019–2020 PICU UP! cohort, across six PICUs, delirium screening occurred on only 57% of days, despite the presence of established practices. Female gender, patients in the early stages of their PICU stay, and patients not receiving mechanical ventilation were associated with lower odds of daily delirium screening. Our results highlight the need for structured quality improvement processes to both standardize and increase the frequency of delirium screening.
- 4 June 2024
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 25 (10) , 880-888
Delirium Screening in Critically Ill Children: Secondary Analysis of the Multicenter PICU Up! Pilot Trial Dataset, 2019–2020*
OBJECTIVES: To determine the patient-level factors associated with performing daily delirium screening in PICUs with established delirium screening practices. DESIGN: A secondary analysis of 2019–2020 prospective data from the baseline phase of the PICU Up! pilot stepped-wedge multicenter trial (NCT03860168). SETTING: Six PICUs in the United States. PATIENTS: One thousand sixty-four patients who were admitted to a PICU for 3 or more days. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of 1064 patients, 74% (95% CI, 71–76%) underwent delirium screening at least once during their PICU stay. On 57% of the 8965 eligible patient days, screening was conducted. The overall prevalence of delirium was 46% across all screened days, and 64% of screened patients experienced delirium at some point during their PICU stay. Factors associated with greater adjusted odds ratio (aOR) of increased daily delirium screening included PICU stay longer than 15 days compared with 1–3 days (aOR 3.36 [95% CI, 2.62–4.30]), invasive mechanical ventilation as opposed to room air (aOR 1.67 [95% CI, 1.32–2.12]), dexmedetomidine infusions (aOR 1.23 [95% CI, 1.04–1.44]) and propofol infusions (aOR 1.55 [95% CI, 1.08–2.23]). Conversely, decreased aOR of daily delirium screening was associated with female gender (aOR 0.78 [95% CI, 0.63–0.96]), and the administration of continuous infusions of opioids (aOR 0.75 [95% CI, 0.63–0.90]) or ketamine (aOR 0.48 [95% CI, 0.29–0.79]). Neither patient age, the presence of family or physical restraints, or benzodiazepine infusions were associated with daily delirium screening rates. CONCLUSIONS: In the 2019–2020 PICU UP! cohort, across six PICUs, delirium screening occurred on only 57% of days, despite the presence of established practices. Female gender, patients in the early stages of their PICU stay, and patients not receiving mechanical ventilation were associated with lower odds of daily delirium screening. Our results highlight the need for structured quality improvement processes to both standardize and increase the frequency of delirium screening.